Keywords: noscira, ph, ii, trial, ad, drug, gets

Noscira's Ph II trial of AD drug gets go-head in Austria

Article | 10 November 2008

Print This

Noscira, a subsidiary of Spain's Zetia group devoted to the development of drugs for diseases of the nervous system, has ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in